ID   UM-HACC-2A
AC   CVCL_C4UW
SY   University of Michigan-Human Adenoid Cystic Carcinoma-2A
DR   Wikidata; Q116050707
RX   PubMed=30527239;
CC   Population: Caucasian.
CC   Doubling time: 3.47 days (Note=At passages 0 to 4), 2.21 days (Note=At passages 96-100) (PubMed=30527239).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7545; MYB + HGNC; HGNC:7785; NFIB; Name(s)=MYB-NFIB (PubMed=30527239).
CC   Derived from site: In situ; Salivary gland, minor salivary gland; UBERON=UBERON_0001830.
ST   Source(s): PubMed=30527239
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 18
ST   D21S11: 30,31.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 20,21
ST   Penta D: 9,12
ST   Penta E: 7,12
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 14,18
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
RX   PubMed=30527239; DOI=10.1016/j.oraloncology.2018.10.012; PMCID=PMC6294471;
RA   Warner K.A., Herzog A.E., Pearson A.T., Zhang Z.-C., Wu W.-S.,
RA   Divi V., Rodriguez-Ramirez C., Castilho R.M., Polverini P.J., Nor J.E.;
RT   "UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma
RT   cell line.";
RL   Oral Oncol. 87:21-28(2018).
//